Evidence map›Paper›PMID 25705392›Full record

ReviewF1000prime reports2015

The role of mast cells in cancers.

Thiago T Maciel, Ivan C Moura, Olivier Hermine

Abstract readReview
In one paragraph

Review in F1000prime reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 75 papers.

0numbers the graph read from it
0cells of the map it votes in
75citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

75 citing papers in PubMed.

  1. Mast Cells in the Developing Brain.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Deciphering the Role of Mast Cells in HPV-Related Cancers.International journal of molecular sciences · 2025
    Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Tumor-infiltrating mast cells stimulate ICOSJournal of advanced research · 2024
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

15 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Thiago T MacielINSERM UMR 1163, Laboratory of cellular and molecular mechanisms of hematological disorders and therapeutic implications 24 Boulevard du Montparnasse, 75015, Paris France ; Paris Descartes - Sorbonne Paris Cité University, Imagine Institute 24 Boulevard du Montparnasse, 75015, Paris France ; CNRS ERL 8254 24 Boulevard du Montparnasse, 75015, Paris France ; Laboratory of Excellence GR-Ex 24 Boulevard du Montparnasse, 75015, Paris France ; Centre de Référence National des Mastocytoses (CEREMAST) 149 rue de Sèvres, 75015, Paris France.
Ivan C MouraINSERM UMR 1163, Laboratory of cellular and molecular mechanisms of hematological disorders and therapeutic implications 24 Boulevard du Montparnasse, 75015, Paris France ; Paris Descartes - Sorbonne Paris Cité University, Imagine Institute 24 Boulevard du Montparnasse, 75015, Paris France ; CNRS ERL 8254 24 Boulevard du Montparnasse, 75015, Paris France ; Laboratory of Excellence GR-Ex 24 Boulevard du Montparnasse, 75015, Paris France ; Centre de Référence National des Mastocytoses (CEREMAST) 149 rue de Sèvres, 75015, Paris France.
Olivier HermineINSERM UMR 1163, Laboratory of cellular and molecular mechanisms of hematological disorders and therapeutic implications 24 Boulevard du Montparnasse, 75015, Paris France ; Paris Descartes - Sorbonne Paris Cité University, Imagine Institute 24 Boulevard du Montparnasse, 75015, Paris France ; CNRS ERL 8254 24 Boulevard du Montparnasse, 75015, Paris France ; Laboratory of Excellence GR-Ex 24 Boulevard du Montparnasse, 75015, Paris France ; Centre de Référence National des Mastocytoses (CEREMAST) 149 rue de Sèvres, 75015, Paris France ; Service d'Hématologie clinique, Assistance Publique-Hôpitaux de Paris, Hôpital Necker 149 rue de Sèvres, 75015, Paris France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mast cells are immune cells that accumulate in the tumors and their microenvironment during disease progression. Mast cells are armed with a wide array of receptors that sense environment modifications and, upon stimulation, they are able to secrete several biologically active factors involved in the modulation of tumor growth. For example, mast cells are able to secrete pro-angiogenic and growth factors but also pro- and anti-inflammatory mediators. Recent studies have allowed substantial progress in understanding the role of mast cells in tumorigenesis/disease progression but further studies are necessary to completely elucidate their impact in the pathophysiology of cancer. Here we review observations suggesting that mast cells could modulate tumor growth in humans. We also discuss the drawbacks related to observations from mast cell-deficient mouse models, which could have consequences in the determination of a potential causative relationship between mast cells and cancer. We believe that the understanding of the precise role of mast cells in tumor development and progression will be of critical importance for the development of new targeted therapies in human cancers.

Identifiers

PMID25705392
PMCPMC4311277

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.